These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1108599)

  • 1. Preleukemia.
    Reizenstein P
    Acta Med Scand; 1975 Dec; 198(6):433-5. PubMed ID: 1108599
    [No Abstract]   [Full Text] [Related]  

  • 2. [Granulocytic sarcoma in acute non-lymphoblastic leukemia as the terminal phase of multiple myeloma under prolonged treatment with alkylating agents].
    Bernardeschi P; Urbano U
    Haematologica; 1983; 68(5):684-8. PubMed ID: 6416948
    [No Abstract]   [Full Text] [Related]  

  • 3. Alkylating agents as leukemogens in multiple myeloma.
    Karchmer RK; Amare M; Larsen WE; Mallouk AG; Caldwell GG
    Cancer; 1974 Apr; 33(4):1103-7. PubMed ID: 4522494
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelomatosis terminating in acute myelogenic leukaemia.
    Jaeger S
    Scand J Haematol; 1978 May; 20(5):410-2. PubMed ID: 276046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy.
    Alberts DS; Golde DW
    Cancer Res; 1974 Nov; 34(11):2911-4. PubMed ID: 4424360
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Variety in general practice.
    Jacobs P; Dubovsky D; King HS
    S Afr Med J; 1975 Apr; 49(16):650-1. PubMed ID: 49083
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of acute erythroleukemia in B-cell immunoproliferative disorders after prolonged therapy with alkylating drugs.
    Cardamone JM; Kimmerle RI; Marshall EY
    Am J Med; 1974 Nov; 57(5):836-42. PubMed ID: 4216270
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrastructure of acute myeloid leukemia arising in multiple myeloma.
    Skinnider LF; Ghadially FN
    Hum Pathol; 1975 May; 6(3):379-84. PubMed ID: 1055708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemia as a terminal event in nonleukemic hematopoietic disorders.
    Bloomfield CD; Brunning RD
    Semin Oncol; 1976 Sep; 3(3):297-317. PubMed ID: 790581
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute granulous leukemia in multiple myeloma. Apropos of 5 cases].
    Krulik M; Grolleau JY; Audebert AA; Mougeot-Martin M; Harousseau JL; Hervouet D; Debray J
    Sem Hop; 1977 Dec; 53(42):2425-35. PubMed ID: 203043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myelomonocytic leukemia occurred after multiple myeloma treated: a case report].
    Wang TY; Huang XO; Xu CG; Chen XC; Wang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):347-9. PubMed ID: 17441363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma after long-term alkylating agent therapy for multiple myeloma.
    Kapadia SB; Krause JR
    South Med J; 1977 Aug; 70(8):1011-3. PubMed ID: 887963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autopsy case of aplastic anemia-PNH syndrome terminated in acute granulocytic leukemia.
    Hiroshige Y; Matsumoto N; Harima K; Miwa S; Kamei T; Ishihara T
    Nihon Ketsueki Gakkai Zasshi; 1977 Feb; 40(1):16-23. PubMed ID: 267405
    [No Abstract]   [Full Text] [Related]  

  • 14. [The uncertainty of the concept of preleukemia].
    Fischer W; Fölsch E
    Med Klin; 1975 Dec; 70(49):2009-13. PubMed ID: 1107782
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preleukemia].
    Sroczyński J; Pigoń-Wegiel A
    Pol Tyg Lek; 1977 Apr; 32(14):517-9. PubMed ID: 266168
    [No Abstract]   [Full Text] [Related]  

  • 16. Human preleukemia. Identification of a maturation defect in vitro.
    Golde DW; Cline MJ
    N Engl J Med; 1973 May; 288(21):1083-6. PubMed ID: 4512288
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of flow cytometry in the diagnosis and monitoring of malignant hematological disorders.
    Ward MS
    Pathology; 1999 Nov; 31(4):382-92. PubMed ID: 10643011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The preleukemic syndrome. Dysplasia hemopoietica].
    Majolino I; Panizza P; Nalli G; Trpin L; Barosi G; Ascari E
    Recenti Prog Med; 1978 Apr; 64(4):404-45. PubMed ID: 356143
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of acute nonlymphocytic leukaemia (ANLL) in myelomatosis.
    Drivsholm A; Lisse I; Philip P
    Scand J Haematol; 1985 Jul; 35(1):35-7. PubMed ID: 4048861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.